$6.16 Billion Per Drug Approval: Almost Half of Big Pharma Companies Hit Negative R&D Productivity
http://dlvr.it/StRrKm
http://dlvr.it/StRrKm
Private Equity And The Monopolization Of Medical Care
PE firms offer an attractive value proposition: promising to ease physician dissatisfaction by increasing income and reducing insurance hassles. But there are downsides to this bargain, too. http://dlvr.it/Sjhfc4
Comments
Post a Comment